Table 2.
Neoadjuvant and adjuvant treatment modalities.
| Parameter | Group A (n = 131) |
Group B (n = 74) |
P value |
|---|---|---|---|
| Neoadjuvant hormonal therapy (n/%/) | 38 (29.0%) | 33 (44.6%) | 0.025 |
| Adjuvant radiotherapy (ART) (n/%/) | 21 (16.0%) | 27 (36.5%) | 0.001 |
| Adjuvant hormonal therapy (ADT) (n/%/) | 29 (22.1%) | 29 (39.2%) | 0.010 |
| Adjuvant combined (ART & ADT) therapy (n/%/) | 13 (9.9%) | 17 (23.0%) | 0.012 |